Skip to content

Determining Normal Range for Free Light Chains in Serum Among Twins

Normal Range Study for Free Light Chains in Blood Among Identical or Fraternal Twins

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04191057
Enrollment
32
Registered
2019-12-09
Start date
2018-08-15
Completion date
2024-01-01
Last updated
2025-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Myeloma

Keywords

free light chains, healthy twins

Brief summary

The objective of this study is to recruit healthy adult identical and fraternal twins for the collection of one teaspoon of blood to be sent to the Clinical Lab at San Francisco General Hospital. The serum will be tested to determine the reference range for free light chains.

Detailed description

Serum free light chains are used to assist in the diagnosis of multiple myeloma. The test measures kappa (K) and lambda (L) chains, and the calculation of the ratio of kappa to lambda (K/L). Previous studies have shown that the K/L ratio does not change over time (1 year). The hypothesis of this study is that healthy twins will have a K/L ratio that are close to each other in value, suggesting that this ratio is genetically linked.

Interventions

OTHERFree light chains

Blood samples will be collected and analyzed

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Masking description

The participant will not be given the results of the free light chain result

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects 18-80 years. * Must be an identical or fraternal twin (both must be recruited)

Exclusion criteria

* Symptoms suggestive of multiple myeloma (e.g., renal insufficiency, anemia, bone pain) -

Design outcomes

Primary

MeasureTime frameDescription
Free light chain reference rangeOne month after the completion of the enrollmentDetermination of the normal range for free light chains

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026